Addition of rituximab to chlorambucil failed to improve OS in MALT lymphoma Healio Researchers compared chlorambucil (Leukeran, Aspen Global) alone with chlorambucil and rituximab (Rituxan, Genentech/Idec Pharmaceuticals) as initial therapy in a cohort of patients with extranodal marginal-zone B-cell lymphoma of mucosa-associated ... |
